BackARS Pharmaceuticals Overview

ARS Pharmaceuticals Profit Margin

Profitability ratio analysis for SPRY.

Quarterly Profit Margin

-267.26%
↑ 37.22% YoY

As of Mar 2026

Annual Profit Margin (TTM)

-200.00%
↓ 1122.03% YoY

Trailing 12 months ending Mar 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin